Apimeds Pharmaceuticals US APUS
NYSE APUS
$3.10 -0.15 (-4.77%)
As of: Oct 22, 2026 · 3:57 PM EDT

Apimeds Pharmaceuticals US (APUS) Price to Book (2025 - 2026)

Updated

Apimeds Pharmaceuticals US's Price to Book was 0.13 in Q2 2026, down 93.2% from 1.87 a year earlier.

Analysis

Apimeds Pharmaceuticals US (APUS) Price to Book (2025 - 2026) Analysis & Trends

From Q2 2025 onward, Apimeds Pharmaceuticals US has reported Price to Book for 4 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 Apimeds Pharmaceuticals US 5.39 Mn -14.24 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.13
Dec 31, 2025 0.13
Sep 30, 2025 2.74
Jun 30, 2025 1.87
API Access

Apimeds Pharmaceuticals US Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=APUS&period=max&api_key=YOUR_API_KEY